The PRMT5 inhibitor GSK3203591 inhibits growth and induces apoptosis in neuroblastoma, accompanied by changes in the DNA damage response, epitranscriptome and metabolism, and reduces GLS expression. This evidence concerns the gene PRMT5 and neuroblastoma.